280 related articles for article (PubMed ID: 6300551)
21. Parathyroid hormone-related protein in normal and neoplastic canine tissues: immunohistochemical localization and biochemical extraction.
Gröne A; Werkmeister JR; Steinmeyer CL; Capen CC; Rosol TJ
Vet Pathol; 1994 May; 31(3):308-15. PubMed ID: 8053125
[TBL] [Abstract][Full Text] [Related]
22. Frequency and partial characterization of adenylate cyclase-stimulating activity in tumors associated with humoral hypercalcemia of malignancy.
Stewart AF; Insogna KL; Burtis WJ; Aminiafshar A; Wu T; Weir EC; Broadus AE
J Bone Miner Res; 1986 Jun; 1(3):267-76. PubMed ID: 2845726
[TBL] [Abstract][Full Text] [Related]
23. Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups.
Stewart AF; Horst R; Deftos LJ; Cadman EC; Lang R; Broadus AE
N Engl J Med; 1980 Dec; 303(24):1377-83. PubMed ID: 6253785
[TBL] [Abstract][Full Text] [Related]
24. Humoral hypercalcemia of malignancy in canine lymphosarcoma.
Weir EC; Norrdin RW; Matus RE; Brooks MB; Broadus AE; Mitnick M; Johnston SD; Insogna KL
Endocrinology; 1988 Feb; 122(2):602-8. PubMed ID: 2828006
[TBL] [Abstract][Full Text] [Related]
25. Clinical hypocalcemia following surgical resection of apocrine gland anal- sac adenocarcinomas in 3 dogs.
Olsen JA; Sumner JP
Can Vet J; 2019 Jun; 60(6):591-595. PubMed ID: 31156257
[TBL] [Abstract][Full Text] [Related]
26. Hypercalcemia and neoplasia. Biologic, biochemical, and ultrastructural studies of a hypercalcemia-producing Leydig cell tumor of the rat.
Rice BF; Roth LM; Cole FE; MacPhee AA; Davis K; Ponthier RL; Sternberg WH
Lab Invest; 1975 Oct; 33(4):428-39. PubMed ID: 52757
[TBL] [Abstract][Full Text] [Related]
27. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA
Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449
[TBL] [Abstract][Full Text] [Related]
28. A case of temporary severe disequilibrium hypercalcemia.
Kogawa K; Inaba M; Okuno Y; Nishizawa Y; Morii H
Miner Electrolyte Metab; 1994; 20(3):163-8. PubMed ID: 7816007
[TBL] [Abstract][Full Text] [Related]
29. Effects of partial and total colectomy on mineral and acid-base homoeostasis in the rat: magnesium deficiency, hyperphosphaturia and osteopathy, in the presence of high serum 1,25-dihydroxyvitamin D but normal parathyroid hormone.
Croner R; Schwille PO; Erben RG; Gepp H; Stahr K; Rümenapf G; Parth R; Scheuerlein H
Clin Sci (Lond); 2000 Jun; 98(6):649-59. PubMed ID: 10814601
[TBL] [Abstract][Full Text] [Related]
30. Squamous cell carcinoma of the anal sac in five dogs.
Esplin DG; Wilson SR; Hullinger GA
Vet Pathol; 2003 May; 40(3):332-4. PubMed ID: 12724576
[TBL] [Abstract][Full Text] [Related]
31. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
Haq M; Kremer R; Goltzman D; Rabbani SA
J Clin Invest; 1993 Jun; 91(6):2416-22. PubMed ID: 8514854
[TBL] [Abstract][Full Text] [Related]
32. Exocrine pancreatic cancer with humoral hypercalcemia.
Monno S; Nagata A; Homma T; Oguchi H; Kawa S; Kaji R; Furuta S
Am J Gastroenterol; 1984 Feb; 79(2):128-32. PubMed ID: 6695885
[TBL] [Abstract][Full Text] [Related]
33. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
[TBL] [Abstract][Full Text] [Related]
34. Biochemical and histomorphometric characterization of a rat model for humoral hypercalcemia of malignancy.
Insogna KL; Stewart AF; Vignery AM; Weir EC; Namnum PA; Baron RE; Kirkwood JM; Deftos LM; Broadus AE
Endocrinology; 1984 Mar; 114(3):888-96. PubMed ID: 6546543
[TBL] [Abstract][Full Text] [Related]
35. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
[TBL] [Abstract][Full Text] [Related]
36. Abnormal bone and parathyroid histology in carcinoma patients with pseudohyperparathyroidism.
Sharp CF; Rude RK; Terry R; Singer FR
Cancer; 1982 Apr; 49(7):1449-55. PubMed ID: 6277464
[TBL] [Abstract][Full Text] [Related]
37. Hypercalcemia of malignancy--new insights into an old syndrome.
Esbrit P
Clin Lab; 2001; 47(1-2):67-71. PubMed ID: 11214225
[TBL] [Abstract][Full Text] [Related]
38. Effects of humoral hypercalcemia of malignancy on the parathyroid gland in nude mice.
Gröne A; Rosol TJ; Baumgärtner W; Capen CC
Vet Pathol; 1992 Jul; 29(4):343-50. PubMed ID: 1514221
[TBL] [Abstract][Full Text] [Related]
39. Prostaglandins as mediators of hypercalcemia associated with certain types of cancer.
Seyberth HW; Segre GV; Morgan JL; Sweetman BJ; Potts JT; Oates JA
N Engl J Med; 1975 Dec; 293(25):1278-83. PubMed ID: 1186822
[TBL] [Abstract][Full Text] [Related]
40. Hypercalcemia in chronic myelogenous leukemia: evidence for excessive parathyroid hormone secretion.
Molho P; Grange MJ; Guéris J; Ballet JJ; Wautier JL; Tobelem G; Caen JP
Nouv Rev Fr Hematol (1978); 1985; 27(3):189-92. PubMed ID: 3862073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
